T-DM1 Compassonate Use
T-DM1 Expanded Access Program
We have had several posts from members who were disappointed that they were ineligible for trastuzmab-DM1 (T-DM1) clinical trials. We met with several representatives of Genentech while at ASCO to discuss your concerns. Here is some information about T-DM1 trials that may be helpful: The current T-DM1 phase III trial is open to enrollment now for patients who have had no prior treatment with Tykerb (Lapatinib) and / or Xeloda (Capecitabine). The two Phase II trials that have been fully enrolled are no longer available for patients. However, Genentech is committed to opening new trials to address patients’ needs; another Phase II trial of T-DM1 is due to open within the month. In addition, Genentech has recently opened a Phase I/II trial of T-DM1 combined with Pertuzumab that will enroll up to 60 patients: http://clinicaltrials.gov/ct2/show/NCT00875979?term=pertuzumab+TDM1& recr=Open&rank=1 Each trial will have slightly different inclusion / exclusion criteria, but neither have restrictions on what prior treatment(s) patients may have received provided they have not been given T-DM1 or T-DM1 and Pertuzumab. During our conversation, it was clear that Genentech understands your frustrations. We discussed the following possible steps, and will keep you posted as we learn more. 1. Expanded Access – We all agreed that it is premature to offer T-DM1 for compassionate use at this time as the Phase III trial has only recently opened for recruitment and the results from the second phase II trial are not yet available. However Genentech will consider launching an Expanded Access Program after it accumulates sufficient data warranting this. Additional Clinical Trials –Genentech will provide us with the location of new trials as they are opened for recruitment. Warmest Regards Joe |
Joe,
This is good news...thank you for always being on top of things. Jean |
thanks Joe for your support
Kim |
kim.. how are you doing in your trial..
still good i hope.. run to live |
Re: T-DM1 Compassonate Use
Why are tykerb xeloda patients excluded? Ceesun
|
Re: T-DM1 Compassonate Use
Ceesun -
I KNOW of people in the T-DM1 trial in Idaho who HAVE had Tykerb/Xeloda, so am figuring there are several trials underway with DIFFERENT admittance criteria. This is why it is confusing even the oncologists who can't seem to keep track of them. It would be nice if there was a list of each trial and a simplified synopsis for each. I know in my limited experience I have never seen such a wide variety of trials for ONE drug in investigational phases. |
Re: T-DM1 Compassonate Use
Push Genentech at every turn to open this to Compassionate use!
|
Re: T-DM1 Compassonate Use
Reading the articles under which the FDA operates I would think that plenty of data have been captured (not all made public) from the T-DM1 phase II trials in 3rd line setting to justify compassionate use of this drug.
Don't believe companies and oncologists are overly eager to take on the additional paperwork to document unapproved drug's performance that is required by such program. |
Re: T-DM1 Compassonate Use
Thank you so much Joe. You are appreciated.
Sandra |
Re: T-DM1 Compassonate Use
My onc just told me last week, I still wasn't eligible.
|
Re: T-DM1 Compassonate Use
thanks for this very clear explanation....and Steph, Yes, I thought I read somewhere that tykerb use was not an exclusion though I think it is here in Detroit at Karmanos. Thanks for this info to all! Ceesun
|
All times are GMT -7. The time now is 08:15 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021